Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA technology and vaccines

F Brown

    International Journal of Technology Assessment in Health Care
    |January 1, 1994
    PubMed
    Summary
    This summary is machine-generated.

    Recombinant DNA technology has revolutionized vaccine design, with hepatitis B vaccines in widespread use. Further potential exists for engineered vaccines, particularly for rabies, though much remains to be explored.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Author Correction: Tree diversity is changing across tropical Andean and Amazonian forests in response to global change.

    Nature ecology & evolution·2026
    Same author

    Tree diversity is changing across tropical Andean and Amazonian forests in response to global change.

    Nature ecology & evolution·2026
    Same author

    Positive reinforcement for the dentally anxious child.

    British dental journal·2023
    Same author

    Transcriptomic analysis reveals pronounced changes in gene expression due to sub-lethal pyrethroid exposure and ageing in insecticide resistance Anopheles coluzzii.

    BMC genomics·2021
    Same author

    Achievements in genetic engineering and their influence on the control and prevention of animal diseases.

    Revue scientifique et technique (International Office of Epizootics)·2020
    Same author

    Thirty years of biochemical work on foot and mouth disease virus at the Pirbright Institute.

    Revue scientifique et technique (International Office of Epizootics)·2020
    Same journal

    Measuring, Valuing, and Incorporating Patient and Caregiver Productivity Costs in Economic Evaluations: A Scoping Review and Environmental Scan.

    International journal of technology assessment in health care·2026
    Same journal

    ASSESSING COST EFFECTIVENESS IN ONCOLOGY TREATMENT SEQUENCES: A REVIEW OF PATHWAY MODELLING METHODS FOR HEALTH TECHNOLOGY ASSESSMENT.

    International journal of technology assessment in health care·2026
    Same journal

    Practice and challenges of HB-HTA in China: insights from hospital management and clinical perspectives.

    International journal of technology assessment in health care·2026
    Same journal

    Policy Dialogue on Health Technology Assessment in Middle East and North Africa: Reporting from an HTAi initiative.

    International journal of technology assessment in health care·2026
    Same journal

    What is new in the early health technology assessment's new definition?

    International journal of technology assessment in health care·2026
    Same journal

    Incorporating climate impact in health care decisions: new criteria to be tested in the Netherlands.

    International journal of technology assessment in health care·2026
    See all related articles

    Area of Science:

    • Biotechnology
    • Vaccinology
    • Molecular Biology

    Background:

    • Recombinant DNA technology concepts were first described 20 years ago.
    • This technology has led to the development of novel vaccines.
    • Hepatitis B vaccine, an engineered product, has been widely used for nearly a decade.

    Purpose of the Study:

    • To describe the principles of designing new vaccines using recombinant DNA technology.
    • To focus on the design principles for hepatitis B and rabies vaccines.

    Main Methods:

    • Review of principles in recombinant DNA technology application for vaccine design.
    • Focus on specific examples of hepatitis B and rabies vaccines.

    Main Results:

    Related Experiment Videos

  • Hepatitis B vaccine is a successful product of this technology.
  • Other engineered vaccines show promise in laboratory settings.
  • The full potential of recombinant DNA technology in vaccinology is yet to be achieved.

    • Conclusions:

    • Recombinant DNA technology offers significant potential for vaccine development.
    • The principles discussed are key to advancing vaccine design for diseases like hepatitis B and rabies.